Groundbreaking oral cancer treatment enters first human testing
Disease control
Recruiting now
This is the first human study of a new oral medication called DEG6498 for people with advanced solid tumors that haven't responded to standard treatments. Researchers will test different doses in about 100 participants to find the safest amount and monitor for side effects. The s…
Phase: PHASE1 • Sponsor: Degron Therapeutics Co. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC